These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 22641830
1. Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials. Roehr B. BMJ; 2012 May 28; 344():e3767. PubMed ID: 22641830 [No Abstract] [Full Text] [Related]
2. Independent medical research. van der Meer JW, de Gier AM, van Swaaij WP, Katan MB. Neth J Med; 2007 Apr 28; 65(4):124-6. PubMed ID: 17452759 [No Abstract] [Full Text] [Related]
3. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics. Campbell MJ. Pharm Stat; 2011 Apr 28; 10(1):80-1. PubMed ID: 21275038 [No Abstract] [Full Text] [Related]
4. Note from the editor. Freedman R. Am J Psychiatry; 2010 Nov 28; 167(11):1407. PubMed ID: 21041255 [No Abstract] [Full Text] [Related]
5. Falling out with pharma. Whitehead S. Lancet; 2013 Mar 30; 381(9872):1096-7. PubMed ID: 23540851 [No Abstract] [Full Text] [Related]
6. Industry sponsored research. Klotz LH. Can J Urol; 2004 Aug 30; 11(4):2312-3. PubMed ID: 15380051 [No Abstract] [Full Text] [Related]
7. The potential for bias in reporting of industry-sponsored clinical trials. Pyke S, Julious SA, Day S, O'Kelly M, Todd S, Matcham J, Seldrup J. Pharm Stat; 2011 Aug 30; 10(1):74-9. PubMed ID: 21275037 [Abstract] [Full Text] [Related]
8. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials. Matcham J, Julious S, Pyke S, O'Kelly M, Todd S, Seldrup J, Day S. Pharm Stat; 2011 Aug 30; 10(1):70-3. PubMed ID: 20187020 [Abstract] [Full Text] [Related]
9. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM. Food Drug Law J; 2004 Aug 30; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
10. The sins of ghostwriting. Somberg JC. Am J Ther; 2008 Aug 30; 15(4):297-8. PubMed ID: 18645328 [No Abstract] [Full Text] [Related]
11. Expedited industry-sponsored translational research: a seductive but hazardous cocktail? Marks JH. Am J Bioeth; 2008 Mar 30; 8(3):56-8; discussion W1-3. PubMed ID: 18570106 [No Abstract] [Full Text] [Related]
12. 'Interests' in medicine and the inadequacy of disclosure. Kerridge I. Aust N Z J Psychiatry; 2012 Jun 30; 46(6):501-3. PubMed ID: 22679203 [No Abstract] [Full Text] [Related]
13. The corporate coauthor. Fugh-Berman A. J Gen Intern Med; 2005 Jun 30; 20(6):546-8. PubMed ID: 15987332 [Abstract] [Full Text] [Related]
14. Commentary. Snapinn S. Pharm Stat; 2011 Jun 30; 10(1):83-4. PubMed ID: 21275040 [No Abstract] [Full Text] [Related]
15. Ethical issues in the relationships involving medicine and industry. Thomas PS, Tan KS, Yates DH. Intern Med J; 2005 Dec 30; 35(12):732. PubMed ID: 16313554 [No Abstract] [Full Text] [Related]
16. In the dark: drug companies should be forced to publish all the results of clinical trials. Chalmers I. New Sci; 2005 Dec 30; 181(2437):19. PubMed ID: 15139350 [No Abstract] [Full Text] [Related]
17. Conflicts of interest in data monitoring of industry versus publicly financed clinical trials. Lachin JM. Stat Med; 2004 May 30; 23(10):1519-21. PubMed ID: 15122730 [Abstract] [Full Text] [Related]